WOCKHARDT BIO AG FDA Approval ANDA 065319

ANDA 065319

WOCKHARDT BIO AG

FDA Drug Application

Application #065319

Application Sponsors

ANDA 065319WOCKHARDT BIO AG

Marketing Status

Prescription002

Application Products

002FOR SUSPENSION;ORAL400MG/5ML0AMOXICILLINAMOXICILLIN

FDA Submissions

ORIG1AP2007-06-18
LABELING; LabelingSUPPL2AP2021-01-14STANDARD
LABELING; LabelingSUPPL3AP2021-01-14STANDARD

Submissions Property Types

SUPPL1Null15
SUPPL2Null7
SUPPL3Null7

TE Codes

002PrescriptionAB

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 65319
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.